Inhibition of fibrosis with multi-agent therapy in pulmonary fibrosis: Results of a drug library screening
C. Braun, M. Girtman, P. Jenson, M. H. Bourne, J. Chae, T. J. Kottom, A. H. Limper
This study screens FDA-approved drugs to identify synergistic combinations for treating pulmonary fibrosis, finding that azole antifungals may enhance anti-fibrotic effects when combined with existing therapies.
bioRxiv · Jun 29, 2020 · PreprintCell Biology